Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer

Published:2001-09 Issue:42 Volume:20 Page:6073-6083
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Chen Xufeng,Thakkar Hitesh,Tyan Frazier,Gim Suzanna,Robinson Heather,Lee Calvin,Pandey Sanjay K,Nwokorie Chichi,Onwudiwe Nneka,Srivastava Rakesh K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1204736.pdf

Reference87 articles.

1. Ashkenazi A, Dixit VM . 1999 Curr. Opin. Cell Biol. 11: 255–260

2. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH . 1999 J. Clin. Invest. 104: 155–162

3. Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, Blenis J, Tschopp J . 2000 Nat. Cell Biol. 2: 241–243

4. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME . 1999 Cell 96: 857–868

5. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME . 2001 Mol. Cell. Biol. 21: 952–965

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology in Brain Arteriovenous Malformations: Focus on Endothelial Dysfunctions and Endothelial-to-Mesenchymal Transition;Biomedicines;2024-08-07

2. Enhancing carboplatin sensitivity in ovarian cancer cells by blocking the mercapturic acid pathway transporter;Carcinogenesis;2024-07-25

3. In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors;OncoImmunology;2024-07-18

4. MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists;Cell Death & Disease;2023-11-02

5. Regression of ovarian cancer xenografts by depleting or inhibiting RLIP;Biochemical Pharmacology;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3